Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

STAT5 alters the state of transcriptional networks, driving aggressive leukemia

The transcription factor STAT5 acts as an oncoprotein in B cell acute lymphoblastic leukemia, competing with the transcription factors NF-κB and Ikaros for binding to DNA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: STAT5 in aggressive leukemia.

References

  1. Murphy, S.L., Xu, J. & Kochanek, K.D. Natl. Vital Stat. Rep. 61, 1–117 (2013).

    PubMed  Google Scholar 

  2. Inaba, H., Greaves, M. & Mullighan, C.G. Lancet 381, 1943–1955 (2013).

    Article  Google Scholar 

  3. Katerndahl, C.D.S. et al. Nat. Immunol. 18, 694–704 (2017).

    Article  CAS  Google Scholar 

  4. Heltemes-Harris, L.M. & Farrar, M.A. Curr. Opin. Immunol. 24, 146–152 (2012).

    Article  CAS  Google Scholar 

  5. Hoelbl, A. et al. EMBO Mol. Med. 2, 98–110 (2010).

    Article  CAS  Google Scholar 

  6. Schwaller, J. et al. Mol. Cell 6, 693–704 (2000).

    Article  CAS  Google Scholar 

  7. Malin, S., McManus, S. & Busslinger, M. Curr. Opin. Immunol. 22, 168–176 (2010).

    Article  CAS  Google Scholar 

  8. Malin, S. et al. Nat. Immunol. 11, 171–179 (2010).

    Article  CAS  Google Scholar 

  9. Mullighan, C.G. et al. Nature 446, 758–764 (2007).

    Article  CAS  Google Scholar 

  10. Whyte, W.A. et al. Cell 153, 307–319 (2013).

    Article  CAS  Google Scholar 

  11. Mullighan, C.G. et al. N. Engl. J. Med. 360, 470–480 (2009).

    Article  CAS  Google Scholar 

  12. Kuiper, R.P. et al. Leukemia 24, 1258–1264 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Sinisa Dovat or Kimberly J Payne.

Ethics declarations

Competing interests

K.J.P. has patent applications related to the treatment of B-ALL and is the founder of Elf Zone, a company that develops cancer therapeutics and tools for cancer research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dovat, S., Payne, K. STAT5 alters the state of transcriptional networks, driving aggressive leukemia. Nat Immunol 18, 597–598 (2017). https://doi.org/10.1038/ni.3747

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.3747

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing